Cite

HARVARD Citation

    Kloos, R. et al. (2019). A cost‐effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia. Pediatric blood & cancer. 66 (1), p. n/a. [Online]. 
  
Back to record